Neoplasma

Subscription or hybridBiochemistry, Genetics and Molecular Biology

Cost to publish

Subscription

No open-access fee found. Publishing is typically free to the author.

Time to publication

Not reported to DOAJ.

h-index

58

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

2.2

Average citations to articles from the previous two years.

What it costs to publish here

We could not find a published fee for Neoplasma. As a subscription or hybrid journal, publishing is normally free unless you choose the open-access option.

Peer review and licensing

Review modelNot reported
LicenceNot reported
Author keeps copyrightNot reported
Plagiarism screeningNot reported
Editorial boardNot linked in DOAJ
LanguagesNot reported

Verification checks

2 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsNot listed. Many legitimate subscription journals are not in DOAJ, so this alone means little.Not confirmed
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
  • Peer review model publicly declaredNo declared model found in DOAJ.Not confirmed
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Not confirmed
  • Screens submissions for plagiarismReported to DOAJ by the journal.Not confirmed
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Not confirmed
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Not confirmed
  • Still actively publishingMost recent indexed article: 2026.Confirmed

Scope

The subjects Neoplasma publishes most, derived from the topics assigned to its indexed articles.

Cancer-related molecular mechanisms researchMicroRNA in disease regulationRNA modifications and cancerCircular RNAs in diseasesCancer, Hypoxia, and MetabolismEpigenetics and DNA MethylationCancer Cells and MetastasisLung Cancer Treatments and MutationsCancer-related gene regulationFerroptosis and cancer prognosis

Publication record

Indexed articles1,796
Total citations28,960
i10-index989
Most recent indexed article2026
All ISSNs0028-2685, 1338-4317

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.